Modulation of [3H]mazindol binding sites in rat striatum by dopaminergic agents
- 1 December 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 250 (2) , 261-266
- https://doi.org/10.1016/0014-2999(93)90390-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of actionPublished by Elsevier ,2002
- Cloning and Expression of a Cocaine-Sensitive Rat Dopamine TransporterScience, 1991
- Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamineNeuropharmacology, 1991
- Ca2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmissionEuropean Journal of Pharmacology, 1989
- Biochemical and Pharmacological Characterization of [3H]GBR 12935 Binding In Vitro to Rat Striatal Membranes: Labeling of the Dopamine Uptake ComplexJournal of Neurochemistry, 1987
- Effect of Chronic Desipramine Treatment on Dihydroalprenolol, Imipramine, and Desipramine Binding Sites: A Quantitative Autoradiographic Study in the Rat BrainJournal of Neurochemistry, 1986
- Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiographyJournal of Neuroscience, 1985
- The effects of surgical and chemical lesions on striatal binding: Correlation with [3H]dopamine uptakeEuropean Journal of Pharmacology, 1985
- [3H]mazindol binding associated with neuronal dopamine uptake sites in corpus striatum membranesEuropean Journal of Pharmacology, 1983
- Recognition Sites for Norepinephrine Uptake: Regulation by NeurotransmitterScience, 1983